4th Quarter - Report

POWERS PYLES SUTTER & VERVILLE, P.C. for HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug price monitoring; H.R. 1730, S. 741 The Cancer Drug Parity Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act.

LobbyistCovered position, as disclosed
JEREMY SCOTT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th), S. 741 (116th), H.R. 1730 (116th), H.R. 133 (116th)

Budget/Appropriations BUD

FY 2021 Labor, Health and Human Services, Education, and Related Agencies; H.R. 8337, FY 2021 Continuing Appropriations Resolution.

LobbyistCovered position, as disclosed
JEREMY SCOTT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8337 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.